换一批
换一批Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.
作者：
Thorsten,Langer [1]
;
Eva,Clemens [2]
;
Linda,Broer [3]
;
Lara,Maier [4]
;
André G,Uitterlinden [3]
;
Andrica C H,de Vries [2]
;
Martine,van Grotel [5]
;
Saskia F M,Pluijm [5]
;
Harald,Binder [6]
;
Benjamin,Mayer [7]
;
Annika,von dem Knesebeck [1]
;
Julianne,Byrne [8]
;
Eline,van Dulmen-den Broeder [9]
;
Marco,Crocco [10]
;
Desiree,Grabow [11]
;
Peter,Kaatsch [11]
;
Melanie,Kaiser [11]
;
Claudia,Spix [11]
;
Line,Kenborg [12]
;
Jeanette F,Winther [13]
;
Catherine,Rechnitzer [14]
;
Henrik,Hasle [15]
;
Tomas,Kepak [16]
;
Anne-Lotte F,van der Kooi [17]
;
Leontien C,Kremer [18]
;
Jarmila,Kruseova [19]
;
Stefan,Bielack [20]
;
Benjamin,Sorg [20]
;
Stefanie,Hecker-Nolting [20]
;
Claudia E,Kuehni [21]
;
Marc,Ansari [22]
;
Martin,Kompis [23]
;
Heleen,van der Pal [18]
;
Ross,Parfitt [24]
;
Dirk,Deuster [24]
;
Peter,Matulat [24]
;
Amelie,Tillmanns [24]
;
Wim J E,Tissing [25]
;
Jörn D,Beck [26]
;
Susanne,Elsner [27]
;
Antoinette,Am Zehnhoff-Dinnesen [24]
;
Marry M,van den Heuvel-Eibrink [2]
;
Oliver,Zolk [28]
;
PanCareLIFE consortium
作者单位：
Department of Pediatric Oncology and Hematology, University Hospital for Children and Adolescents, Lübeck, Germany.
[1]
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Erasmus MC - Sophia Children's Hospital, Rotterdam, the Netherlands.
[2]
Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
[3]
Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University Medical Center, Ulm, Germany.
[4]
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
[5]
German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany; Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
[6]
Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
[7]
Boyne Research Institute, Drogheda, Ireland.
[8]
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Hematology and Oncology, VU Medical Center, Amsterdam, the Netherlands.
[9]
Department of Neurooncology, Istituto Giannina Gaslini, Genova, Italy.
[10]
German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
[11]
Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark.
[12]
Danish Cancer Society Research Center, Childhood Cancer Research Group, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
[13]
Copenhagen University Hospital Rigshospitalet, Department of Pediatrics and Adolescent Medicine, Copenhagen, Denmark.
[14]
Aarhus University Hospital, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark.
[15]
University Hospital Brno, Brno, Czech Republic; International Clinical Research Center (FNUSA-ICRC), Brno, Czech Republic.
[16]
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Obstetrics and Gynecology, Erasmus MC - Sophia Children's Hospital, the Netherlands.
[17]
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, Academic Medical Center Amsterdam, Amsterdam, the Netherlands.
[18]
Department of Children Hemato-Oncology, Motol University Hospital Prague, Prague, Czech Republic.
[19]
Department of Pediatric Oncology, Hematology, Immunology, Stuttgart Cancer Center, Olgahospital, Stuttgart, Germany.
[20]
Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; Paediatric Oncology, Dept. of Paediatrics, Inselspital, University of Bern, Switzerland.
[21]
Department of Pediatrics, Oncology and Hematology Unit, University Hospital of Geneva, Cansearch Research Laboratory, Geneva University, Switzerland.
[22]
Department of Otolaryngology, Head and Neck Surgery, Inselspital, University of Berne, Switzerland.
[23]
Department of Phoniatrics and Pedaudiology, University Hospital Münster, Westphalian Wilhelm University, Münster, Germany.
[24]
Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
[25]
Hospital for Children and Adolescents, University of Erlangen-Nuremberg, Erlangen, Germany.
[26]
Institute for Social Medicine and Epidemiology, University of Lübeck, Lübeck, Germany.
[27]
Institute of Clinical Pharmacology, Immanuel Klinik Rüdersdorf, Brandenburg Medical School Theodor Fontane, Germany; Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University Medical Center, Ulm, Germany. Electronic address: oliver.zolk@mhb-fontane.de.
[28]
主题词
青少年(Adolescent);发病年龄(Age of Onset);抗肿瘤药(Antineoplastic Agents);卡铂(Carboplatin);儿童(Child);儿童, 学龄前(Child, Preschool);顺铂(Cisplatin);横断面研究(Cross-Sectional Studies);欧洲(Europe);女(雌)性(Female);遗传关联研究(Genetic Association Studies);疾病遗传易感性(Genetic Predisposition to Disease);听力(Hearing);听觉丧失, 感音神经性(Hearing Loss, Sensorineural);人类(Humans);婴儿(Infant);婴儿, 新生(Infant, Newborn);男(雄)性(Male);肿瘤(Neoplasms);多态性, 单核苷酸(Polymorphism, Single Nucleotide);前瞻性研究(Prospective Studies);回顾性研究(Retrospective Studies);危险性评估(Risk Assessment);危险因素(Risk Factors)
DOI
10.1016/j.ejca.2020.07.019
PMID
32905960
发布时间
2021-01-25
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
